 |
인쇄하기
취소
|
Daewoong enters agreement with Medivir for markeing rights to cold sore treatment Xerclear
Daewoong Pharm says it has signed an agreement with Swenden-based Medivir AB to distribute Medivir’s Xerclear (acyclovir and hydrocortisone) for non-prescription use (OTC) in Korea.
Xerclear is the first and only topical herpes labialis (cold sores) treatment clinically proven to help prevent cold sore lesions appearing.
“This alliance will help strengthen our dermatology portfolio here,”...
Xerclear is the first and only topical herpes labialis (cold sores) treatment clinically proven to help prevent cold sore lesions appearing.
“This alliance will help strengthen our dermatology portfolio here,”...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.